Delivery Order SPE2DB20D2104-SPE2DB23FV13T
- Not listed
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A 2ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of February 13, 2024 and a ceiling value of $1,175.24. The contract is a Delivery Order awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which has an Indefinite...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic medication, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,607.08, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 19, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,246.04 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 15, 2022, with a completion date of December 16, 2022. This delivery order is placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $115,506.70. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 24, 2024. The contract is not designated with a set-aside...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $180,186.72, was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,647.58, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of December 5, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, to the Defense Logistics Agency (DLA). The $1,072.54 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 10, 2023, with a completion date of March 13, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A 2 mL, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a Delivery Order with a Firm Fixed Price of $115,368.80. The contract has an Ultimate Completion Date of October 28, 2024 and was awarded on October 25, 2024. The contract is not designated with a set-aside requirement,...
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $3,844.24 and an ultimate completion date of December 7, 2023. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract was awarded on December 6, 2023, and does not have a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $76,391.25 and was awarded on May 13, 2024, with a completion date of May 14, 2024. The prime contractor is Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc., which is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV13TDelivery Order
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of 1,200,000 units of Bicillin L-A (2 mL) to the DLA Troop Support Medical division. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award has a ceiling value of $1,072.54 and is a firm fixed-price delivery order contract, with an ultimate completion date of September 1, 2023. This contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/31/23 |